| Application number | Title of the application | Filing Date | Status |
|---|
| 09/445258 | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAS ENCODING THESE PROTEINS | Nov 30, 1999 | Abandoned |
Array
(
[id] => 1148221
[patent_doc_number] => 06774226
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/451739
[patent_app_country] => US
[patent_app_date] => 1999-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8590
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/774/06774226.pdf
[firstpage_image] =>[orig_patent_app_number] => 09451739
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/451739 | Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof | Nov 29, 1999 | Issued |
Array
(
[id] => 6594305
[patent_doc_number] => 20020042127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'DONOR CELLS EXPRESSING FUSOGENS'
[patent_app_type] => new
[patent_app_number] => 09/444802
[patent_app_country] => US
[patent_app_date] => 1999-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12376
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042127.pdf
[firstpage_image] =>[orig_patent_app_number] => 09444802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/444802 | DONOR CELLS EXPRESSING FUSOGENS | Nov 21, 1999 | Abandoned |
| 09/269071 | IMMUNOLOGICAL COMPOSITION FOR DETECTION OF BLADDER CANCER AND METHOD OF USING SAME | Nov 18, 1999 | Abandoned |
| 09/442898 | USES FOR EPH RECEPTOR ANTAGONISTS AND AGONISTS | Nov 17, 1999 | Abandoned |
| 09/402474 | USE OF MICROPARTICLES HAVING A PROTEIN AND AN ANTIBODY ADSORBED THEREON FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR INTRANASAL ADMINISTRATION | Nov 17, 1999 | Abandoned |
| 09/441239 | THERAPEUTIC OR PROPHYLACTIC COMPOSITION OF FIBRONECTIN-BINDING PROTEIN I (SFBI) AS ADJUVANT | Nov 15, 1999 | Abandoned |
| 09/439901 | COMPOSITIONS AND METHODS FOR ANTIANGIOGENIC SCHEDULING | Nov 11, 1999 | Abandoned |
| 09/434197 | NOVEL METHODS OF DIAGNOSIS OF ANGIOGENESIS AND OTHER CONDITIONS, COMPOSITIONS, AND METHODS OF SCREENING FOR MODULATORS | Nov 3, 1999 | Abandoned |
Array
(
[id] => 6274675
[patent_doc_number] => 20020106359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'METHOD AND COMPOSITION FOR TREATING PROSTATE CANCER'
[patent_app_type] => new
[patent_app_number] => 09/428375
[patent_app_country] => US
[patent_app_date] => 1999-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9365
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106359.pdf
[firstpage_image] =>[orig_patent_app_number] => 09428375
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/428375 | Method and composition for treating prostate cancer | Oct 27, 1999 | Issued |
Array
(
[id] => 1338400
[patent_doc_number] => 06589725
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Tankyrase H, compositions involved in the cell cycle and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/427154
[patent_app_country] => US
[patent_app_date] => 1999-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26956
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09427154
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/427154 | Tankyrase H, compositions involved in the cell cycle and methods of use | Oct 24, 1999 | Issued |
Array
(
[id] => 1478407
[patent_doc_number] => 06344549
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'ATR-2 cell cycle checkpoint'
[patent_app_type] => B1
[patent_app_number] => 09/417822
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34291
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344549.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417822
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417822 | ATR-2 cell cycle checkpoint | Oct 13, 1999 | Issued |
| 09/418527 | TUMOR ANTIGEN-DERIVED GENE 16 (TADG-16): A NOVEL EXTRACELLULAR SERINE PROTEASE AND USES THEREOF | Oct 13, 1999 | Abandoned |
Array
(
[id] => 1542072
[patent_doc_number] => 06372444
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'SODD gene expression in cancer'
[patent_app_type] => B1
[patent_app_number] => 09/417559
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10140
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372444.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417559 | SODD gene expression in cancer | Oct 12, 1999 | Issued |
| 09/402468 | THERAPEUTIC, PROPHYLACTIC AND DIAGNOSTIC AGENT FOR CANCER, USEFUL FOR CHARACTERISING CANCER CELLS WITH INDIVIDUAL PROPERTIES | Oct 11, 1999 | Abandoned |
Array
(
[id] => 4212954
[patent_doc_number] => 06110690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'SODD-specific antibodies and methods'
[patent_app_type] => 1
[patent_app_number] => 9/416213
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5734
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110690.pdf
[firstpage_image] =>[orig_patent_app_number] => 416213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416213 | SODD-specific antibodies and methods | Oct 7, 1999 | Issued |
Array
(
[id] => 1520467
[patent_doc_number] => 06413728
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Methods for detecting SODD genes and proteins'
[patent_app_type] => B1
[patent_app_number] => 09/416214
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5579
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413728.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416214 | Methods for detecting SODD genes and proteins | Oct 7, 1999 | Issued |
Array
(
[id] => 6128395
[patent_doc_number] => 20020076413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING ANGIOGENESIS'
[patent_app_type] => new
[patent_app_number] => 09/414834
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12753
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09414834
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414834 | Compositions and methods for inhibiting angiogenesis | Oct 7, 1999 | Issued |
Array
(
[id] => 1178911
[patent_doc_number] => 06743906
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-01
[patent_title] => 'PPP2R1B is a tumor suppressor'
[patent_app_type] => B1
[patent_app_number] => 09/410416
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 45343
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743906.pdf
[firstpage_image] =>[orig_patent_app_number] => 09410416
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410416 | PPP2R1B is a tumor suppressor | Sep 30, 1999 | Issued |
Array
(
[id] => 1546436
[patent_doc_number] => 06444802
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Human aminopeptidase'
[patent_app_type] => B1
[patent_app_number] => 09/409180
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 33501
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444802.pdf
[firstpage_image] =>[orig_patent_app_number] => 09409180
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/409180 | Human aminopeptidase | Sep 29, 1999 | Issued |
